Bevacizumab Biosimilar, Anti-human VEGF Monoclonal Antibody
$125.00 – $1,000.00
The research grade bevacizumab biosimilar, anti-human VEGF monoclonal antibody, can be used for ELISA, neutralization, in vitro and in vivo functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by bevacizumab . The research grade bevacizumab biosimilar protein is for research use only.
Synonyms: VEGF, VEGF-A, vascular endothelial growth factor A, anti-VEGF